JOHNSON & JOHNSON is 246.7x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($574.10 B vs $2.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PBH | JNJ |
|---|---|---|
| Market cap | $2.33 B | $574.10 B |
| US-listed rank | #1987 | #20 |
| Revenue (latest FY) | $1.09B | $94.19B |
| Net income (latest FY) | $190.30M | $26.80B |
| Net margin | 17.5% | 28.5% |
| P/E (trailing FY) | 12.2 | 21.4 |
| SEC filings | 1,235 | 984 |
JOHNSON & JOHNSON is 246.7x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($574.10 B vs $2.33 B).
In their latest fiscal years, Prestige Consumer Healthcare Inc. reported $1.09B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Prestige Consumer Healthcare Inc. and JOHNSON & JOHNSON, or browse the full rankings.